The effects of dietary intervention on HIV dyslipidaemia: A systematic review and meta-analysis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Stradling, Clare ^a,b   Chen, Yen Fu ^b   Russell, Tracy ^c   Connock, Martin ^d   Thomas, G Neil ^b   Taheri, Shahrad ^a,b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; CHOLESTEROL; CHROMIUM; DOCOSAHEXAENOIC ACID; FENOFIBRATE; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 ACID ETHYL ESTER; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE CONTROL; DYSLIPIDEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KINESIOTHERAPY; LIPID BLOOD LEVEL; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION; YOGA; BLOOD; REVIEW; STATISTICAL MODEL;

CHOLESTEROL; DIETARY SUPPLEMENTS; DYSLIPIDEMIAS; FATTY ACIDS, OMEGA-3; HIV INFECTIONS; HUMANS; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84862163853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038121     Document Type: Article

References (58)

1. Dube MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, (2003) Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 37: 613 627.
2. Gazzard BG, Anderson J, Babiker A, Boffito M, Brook G, (2008) British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 9: 563 608.
3. Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, (2008) European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med 9: 72 81.
4. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A, (2008) Adherence to Mediterranean diet and health status: meta-analysis. BMJ 337: a1334.
5. Hjerkinn EM, Sandvik L, Hjermann I, Arnesen H, (2004) Effect of diet intervention on long-term mortality in healthy middle-aged men with combined hyperlipidaemia. J Intern Med 255: 68 73.
6. McGoldrick C, Leen CL, (2007) The management of dyslipidaemias in antiretroviral-treated HIV infection: a systematic review. HIV Med 8: 325 334.
7. Leyes P, Martinez E, Forga M, (2008) Use of diet, nutritional supplements and exercise in HIV-infected patients receiving combination antiretroviral therapies: a systematic review. Antivir Ther 13: 149 159.
8. Almeida LB, Giudici KV, Jaime PC, (2009) [Dietary intake and dyslipidemia arising from combination antiretroviral therapy for HIV infection: a systematic review]. Arq Bras Endocrinol Metabol 53: 519 527.
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, G√∏tzsche PC, (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700.
10. Higgins J, Green S, (2009) Cochrane Handbook for Systematic reviews of interventions. version 5.0 [updated September 2009] Available from www.cochrane-handbook.org: The Cochrane Collaboration.
11. CochraneCollaboration (2008) Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration.
12. Peabody D, Remple V, Green T, Kalmar A, Frohlich J, (2002) The triglyceride-lowering effect of omega-3 fatty acids in HIV-infected patients on HAART. XIV World AIDS Conference: Abstract ThPeB7343.
13. Thanasilp S, (2009) Effects of symptom management combine with complementary care program (SMCCP) on low density lipoprotein (LDL) and high density lipoprotein (HDL) among female living with HIV (FLWHIV) 5th IAS Conference on HIV Pathogenesis and Treatment: Abstract CDB0235.
14. Sanchez M, Belloso W, Rey R, Clara L, Barcan L, (2006) Adherence to a diet and exercise program produces significant increases in HDL levels without worsening of lipoatrophy in patients under antiretroviral treatment (Lunes Study). XVI International AIDS Conference Abstract CDB0680.
15. Thusgaard M, Christensen JH, Morn B, Andersen TS, Vige R, (2009) Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: A randomized, double-blind, placebo-controlled study. Scand J Infect Dis 41: 760 766.
16. Carter VM, Woolley I, Jolley D, Nyulasi I, Mijch A, (2006) A randomised controlled trial of omega-3 fatty acid supplementation for the treatment of hypertriglyceridemia in HIV-infected males on highly active antiretroviral therapy. Sexual Health 3: 287 290.
17. De Truchis P, Kirstetter M, Perier A, Meunier C, Zucman D, (2007) Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: A randomized prospective study. J of Acquir Immune Defic Syndr 44: 278 285.
18. Hadigan C, Liebau J, Torriani M, Andersen R, Grinspoon S, (2006) Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia. J Clin Endocrinol Metab 91: 4438 4444.
19. Aghdassi E, Arendt BM, Salit IE, Mohammed SS, Jalali P, (2010) In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial. Current HIV Research 8: 113 120.
20. Peters BS, Wierzbicki AS, Moyle G, Nair D, Brockmeyer N, (2012) The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial. Clinical Therapeutics 34: 67 76.
21. Gerber JG, Kitch DW, Fichtenbaum CJ, Zackin RA, Charles S, (2008) Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: Results of ACTG A5186. Journal of Acquired Immune Deficiency Syndromes 47: 459 466.
22. Ng GWB, Chan UMS, Li PCK, Wong WCW, (2011) Can a Mediterranean diet reduce the effects of lipodystrophy syndrome in people living with HIV? A pilot randomised controlled trial. Sexual Health 8: 43 51.
23. Lazzaretti R, Kuhmmer R, Sprinz E, Polanczyk C, Ribeiro J, (2012) Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in Human Immunodeficiency Virus type 1-infected individuals: a randomized trial. J Am Coll Cardiol 59: 979 988.
24. Woods MN, Wanke CA, Ling PR, Hendricks KM, Tang AM, (2009) Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV. American Journal of Clinical Nutrition 90: 1566 1578.
25. Chow DC, Stein JH, Seto TB, Mitchell C, Sriratanaviriyakul N, (2010) Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy. AIDS 24: 1019 1023.
26. National Cholesterol Education Program (NCEP) Expert Panel (2002) Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106: 3143 3421.
27. Fitch KV, Anderson EJ, Hubbard JL, Carpenter SJ, Waddell WR, (2006) Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome. AIDS 20: 1843 1850.
28. Balasubramanyam A, Coraza I, Smith EO, Scott LW, Patel P, (2011) Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial. J Clin Endocrinol Metab 96: 2236 2247.
29. Baril JG, Kovacs CM, Trottier S, Roederer G, Martel AY, (2007) Effectiveness and tolerability of oral administration of low-dose salmon oil to HIV patients with HAART-associated dyslipidemia. HIV Clinical Trials 8: 400 411.
30. Wohl DA, Tien HC, Busby M, Cunningham C, MacIntosh B, (2005) Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Clinical Infectious Diseases 41: 1498 1504.
31. Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343: d4002.
32. Kelley G, Kelley K, Roberts S, Haskell W, (2011) Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. BMC Medicine 9: 74.
33. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, (1999) Effects of the national cholesterol education program's step I and step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 69: 632 646.
34. Van Horn L, McCoin M, Kris-Etherton PM, Burke F, Carson JA, (2008) The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc 108: 287 331.
35. Kelley G, Kelley K, Tran Z, (2004) Aerobic exercise and lipids and lipoproteins in women: a meta-analysis of randomized controlled trials. J Womens Health 13: 1148 1164.
36. Kelley G, Kelley K, (2006) Aerobic exercise and lipids and lipoproteins in men: a meta-analysis of randomized controlled trials. J Men's Health Gend 3: 61 70.
37. Brunner E, Rees K, Ward K, Burke M, Thorogood M, (2007) Dietary advice for reducing cardiovascular risk. Cochrane Database of Systematic Reviews.
38. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, (2003) Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290: 502 510.
39. Jenkins DJA, Jones PJH, Lamarche B, Kendall CWC, Faulkner D, (2011) Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia. JAMA: The Journal of the American Medical Association 306: 831 839.
40. Barrios A, Blanco F, Garcia-Benayas T, Gomez-Viera JM, de la Cruz JJ, (2002) Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia. AIDS 16: 2079 2081.
41. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, (2011) Triglycerides and Cardiovascular Disease. Circulation 123: 2292 2333.
42. Mutimura E, Crowther NJ, Cade TW, Yarasheski KE, Stewart A, (2008) Exercise training reduces central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: A randomized controlled trial. AIDS Research and Human Retroviruses 24: 15 23.
43. Dolan SE, Frontera W, Librizzi J, Ljungquist K, Juan S, (2006) Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial. Arch Intern Med 166: 1225 1231.
44. Terry L, Sprinz E, Stein R, Medeiros NB, Oliveira J, (2006) Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy. Medicine and Science in Sports and Exercise 38: 411 417.
45. Hartweg J, Perera R, Montori Victor M, Dinneen Sean F, Neil Andrew H, (2008) Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews.
46. Eslick GD, Howe PR, Smith C, Priest R, Bensoussan A, (2009) Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. International Journal of Cardiology pp. 4 16.
47. Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B,et al. (March 2004) Effects of Omega-3 Fatty Acids on Cardiovascular Risk Factors and Intermediate Markers of Cardiovascular Disease. Rockville, MD: Agency for Healthcare Research and Quality: Tufts- New England Medical Center Evidence-based Practice Center.
48. Marik PE, Varon J, (2009) Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clinical Cardiology pp. 365 372.
49. Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, (2009) Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Annals of Medicine pp. 301 310.
50. Leon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, (2009) Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 338: a2931.
51. Filion KB, El Khoury F, Bielinski M, Schiller I, Dendukuri N, (2010) Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders.
52. Eckel RH, (2010) The Fish Oil Story Remains Fishy. Circulation 122: 2110 2112.
53. Heaney RP, (2008) Nutrients, Endpoints, and the Problem of Proof. The Journal of Nutrition 138: 1591 1595.
54. Saha SA, Kizhakepunnur LG, Bahekar A, Arora RR, (2007) The role of fibrates in the prevention of cardiovascular disease-a pooled meta-analysis of long-term randomized placebo-controlled clinical trials. Am Heart J 154: 943 953.
55. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, (2006) Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: sytematic review. BMJ pp. 752 760.
56. Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC, (2005) Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 165: 725 730.
57. Astrup A, Dyerberg J, Elwood PC, Hermansen K, Hu FB, (2011) The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr 93: 684 688.
58. Worm SW, Kamara DA, Reiss P, Kirk O, El-Sadr W, (2011) Elevated triglycerides and risk of myocardial infarction in HIV-positive persons. AIDS 25: 1497-1504 1410.1097/QAD.1490b1013e32834917c32834916.